Legal News

Life Sciences weekly highlights—18 March 2021

Published on: 18 March 2021
Published by: LexisPSL
  • Life Sciences weekly highlights—18 March 2021
  • In this issue:
  • Brexit
  • Updated MHRA guidance—two-year notice period to amend recognition of EU batch testing
  • Amending Regulation on derogation from wholesalers’ obligation to decommission unique identifier of products exported to UK published in Official Journal
  • Coronavirus (COVID-19)
  • Gove outlines plans to review coronavirus (COVID-19) status certificates
  • Coronavirus (COVID-19)—European Commission proposes a Digital Green Certificate
  • MHRA responds to Ireland’s suspension of AstraZeneca coronavirus (COVID-19) vaccine
  • MHRA response to AstraZeneca coronavirus (COVID-19) vaccine suspension
  • More...

Article summary

This week's edition of Life Sciences weekly highlights includes news that the MHRA has introduced a two-year notice period for any changes to the continued recognition of EU batch testing, updates on the UK and EU plans to introduce coronavirus (COVID-19) vaccine certificates, the revised go-live date for the EU IT systems required by Regulation (EU) 536/2014, the Clinical Trials Regulation, to 31 January 2022, and the Medical Device Co-ordination Group’s Q&A guidance on custom-made medical devices. or take a trial to read the full analysis.

Popular documents